Tovelu Home
Reversal Velocity

Master Goals & Status

Primary Clinical Destination

Type-2 Diabetes Reversal & Remission

Target: HbA1c < 5.7% with 0 pharmaceutical dependency

78% Done
Baseline (May 15) 78% Reversal Complete Goal: Remission
Projected Remission Date Nov 28, 2026 ⚡ 14 Days Ahead of Schedule
Weekly Reversal Velocity +2.1% / week Status: Accelerated 🟢
🎯

Your 3 Active Master Goals

Multi-select synergies calculated by THAIS Core

3 / 3 Selected
🩺
G5: Reverse Sugar & Prediabetes Primary

Clear cellular insulin resistance & achieve euglycemic remission.

88%
HbA1c: 8.4% ➔ 5.9% Goal: < 5.7%
🔥
G1: Lose Stubborn Belly Fat Synergy G5+G7

Trim waistline & deplete deep visceral fat surrounding pancreas.

78%
Waist: 94cm ➔ 83cm (-11cm) Goal: < 80cm
🌿
G7: Detox Fatty Liver (MASLD) Completed 🎉

Eliminate intra-hepatic lipid droplets and normalize ALT enzymes.

100%
ALT: 58 U/L ➔ 22 U/L Milestone Verified ✅
⚡

Velocity Drivers & Friction Leaks

Real actions directly altering your completion ETA

🟢 Drivers Accelerating Your Completion Date:
16h Circadian Fasting Adherence (21 Days Straight) +4.5 Days Ahead

Accelerated hepatic glycogen emptying and nocturnal autophagy.

15-Min Post-Dinner Strolls (GLUT4 Clearance) +2.0 Days Ahead

Prevented nocturnal insulin surges and protected deep restorative sleep.

🔴 Friction Leaks Slowing Down Your Velocity:
2 Late Weekend Dinners (Eaten past 09:15 PM) -1.5 Days Delay

Caused nocturnal resting heart rate elevation and impaired early fat burn.

🏆

Deprescribing Freedom Ladder

Coordinated tapering off medications with physician

✅
Milestone 1: Halve Metformin to 500mg

Achieved on Sep 10 by Dr. Rajiv Verma due to HbA1c falling to 5.9%.

Completed
⏳
Milestone 2: Discontinue BP Telmisartan

Scheduled for Nov 15 review. Blood pressure currently stable at 118/76 mmHg.

75% Ready
🏁
Milestone 3: 100% Drug-Free Remission Discharge

Target: Dec 30, 2026. Zero pharmaceutical intake with pristine metabolic bio-markers.

Final Target
Toast message